Your browser doesn't support javascript.
loading
Rituximab for auto-immune alveolar proteinosis, a real life cohort study.
Soyez, Berenice; Borie, Raphael; Menard, Cedric; Cadranel, Jacques; Chavez, Leonidas; Cottin, Vincent; Gomez, Emmanuel; Marchand-Adam, Sylvain; Leroy, Sylvie; Naccache, Jean-Marc; Nunes, Hilario; Reynaud-Gaubert, Martine; Savale, Laurent; Tazi, Abdellatif; Wemeau-Stervinou, Lidwine; Debray, Marie-Pierre; Crestani, Bruno.
Afiliação
  • Soyez B; Service de Pneumologie A, DHU FIRE, centre de référence constitutif des maladies pulmonaires rares, Hôpital Bichat, APHP, 46 rue Henri Huchard 75877 Paris CEDEX, 18, Paris, France.
  • Borie R; OrphaLung, Lyon, France.
  • Menard C; Service de Pneumologie, Hôpital de la Pitié Salpetrière, APHP, Paris, France.
  • Cadranel J; Service de Pneumologie A, DHU FIRE, centre de référence constitutif des maladies pulmonaires rares, Hôpital Bichat, APHP, 46 rue Henri Huchard 75877 Paris CEDEX, 18, Paris, France. Raphael.borie@aphp.fr.
  • Chavez L; OrphaLung, Lyon, France. Raphael.borie@aphp.fr.
  • Cottin V; INSERM, Unité 1152, Université Paris Diderot, Paris, France. Raphael.borie@aphp.fr.
  • Gomez E; Service d'Immunologie, Thérapie Cellulaire et Hématopoïèse, CHU Pontchaillou, Rennes, France.
  • Marchand-Adam S; OrphaLung, Lyon, France.
  • Leroy S; Service de Pneumologie, Centre de référence constitutif des maladies pulmonaires rares, Hôpital Tenon, APHP, Paris, France.
  • Naccache JM; Service de Pneumologie, Centre de compétences des maladies pulmonaires rares, CHU Grenoble-Alpes, Grenoble, France.
  • Nunes H; OrphaLung, Lyon, France.
  • Reynaud-Gaubert M; Service de Pneumologie, Centre national de référence des maladies pulmonaires rares, Hôpital Louis Pradel, Université Claude Bernard Lyon 1, Lyon, France.
  • Savale L; OrphaLung, Lyon, France.
  • Tazi A; Service de Pneumologie, Centre de compétences des maladies pulmonaires rares CHRU Nancy, Nancy, France.
  • Wemeau-Stervinou L; OrphaLung, Lyon, France.
  • Debray MP; Service de Pneumologie, Centre de compétences des maladies pulmonaires raresCHRU de Tours, Tours, France.
  • Crestani B; OrphaLung, Lyon, France.
Respir Res ; 19(1): 74, 2018 04 25.
Article em En | MEDLINE | ID: mdl-29695229

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteinose Alveolar Pulmonar / Rituximab / Fatores Imunológicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Respir Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteinose Alveolar Pulmonar / Rituximab / Fatores Imunológicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Respir Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França